Worried about menopause weight gain
F.A.Qs Frequently asked questions Originally developed for managing blood sugar levels, GLP-1 treatments have also been shown to facilitate average weight loss of 15 - 23% of starting body weight in clinical studies
Furthermore, when compared to patients not taking any of these other medications, the GLP-1 group displayed a recurrence risk of 14.5%, whereas the comparison group had a risk of 51.6%
If side effects like a rash or significant digestive distress continue for more than a week, it is recommended to stop use and speak with a professional to ensure the supplement is right for you.
CJC-1295 (no DAC) 5mg / Ipamorelin 5mg is not for human or veterinary consumption
Determinants of appetite ratings: the role of age, gender, BMI, physical activity, smoking habits, and diet/weight concern